Search results for "OXY"

showing 10 items of 11443 documents

Understanding benign paroxysmal positional vertigo: the management of lateral canal involvement

2013

Benign paroxysmal positional vertigo (BPPV) represents the most common cause of peripheral vertigo. The treatment of this apparently intractable disease is actually a physical treatment: performing manoeuvres on the patient to restore the normal condition of the inner ear. However, the following information will help readers who are unfamiliar with BPPV to improve their knowledge of the condition.

medicine.medical_specialtyBenign paroxysmal positional vertigobusiness.industryRehabilitationPhysical Therapy Sports Therapy and RehabilitationAudiologyBPPVmedicine.diseaseLateral canalvertigoPhysical medicine and rehabilitationPositional vertigobenign paroxysmal positional vertigomental disordersotorhinolaryngologic diseasesmedicineOrthopedics and Sports Medicinesense organsbusinessdizzinesspsychological phenomena and processesPhysical Therapy Reviews
researchProduct

Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes

2000

Background/aims The accumulation of endogenous bile acids contributes to hepatocellular damage during cholestatic liver disease. To evaluate the potential role of apoptotic cell death due to increased concentrations of bile acids, primary human hepatocytes were treated with hydrophobic and hydrophilic bile acids. Because the Fas receptor–ligand system may mediate apoptosis in human liver cells, the effect of toxic bile acids on hepatocellular Fas receptor expression was evaluated. Materials and methods Primary human hepatocytes were incubated with 50 and 100 μM glycochenodeoxycholic acid (GCDCA) and co-incubated with equimolar concentrations of tauroursodeoxycholic acid (TUDCA). To evaluate…

medicine.medical_specialtyBile acidmedicine.drug_classClinical BiochemistryApoptotic DNA fragmentationTaurochenodeoxycholic acidTauroursodeoxycholic acidGeneral MedicineBiologyFas receptorBiochemistryMolecular biologyUrsodeoxycholic acidchemistry.chemical_compoundEndocrinologychemistryApoptosisInternal medicinemedicineGlycochenodeoxycholic acidmedicine.drugEuropean Journal of Clinical Investigation
researchProduct

Management of Dyslipidemia in the Metabolic Syndrome

2007

In order to characterize the metabolic syndrome it becomes necessary to establish a number of diagnostic criteria. Because of its impact on cardiovascular morbidity/mortality, considerable attention has been focussed on the dyslipidemia accompanying the metabolic syndrome. The aim of this review is to highlight the fundamental aspects of the pathophysiology, diagnosis, and the treatment of the metabolic syndrome dyslipidemia with recommendations to clinicians. The clinical expression of the metabolic syndrome dyslipidemia is characterized by hypertriglyceridemia and low levels of high-density lipoprotein-cholesterol (HDL-C). In addition, metabolic syndrome dyslipidemia is associated with hi…

medicine.medical_specialtyBioinformaticsClofibric Acidchemistry.chemical_compoundInsulin resistanceInternal medicineHyperlipidemiamedicineHumansPharmacology (medical)DyslipidemiasMetabolic Syndromemedicine.diagnostic_testCholesterolbusiness.industryCholesterol HDLHypertriglyceridemianutritional and metabolic diseasesGeneral Medicinemedicine.diseaseEndocrinologyPostprandialchemistrySpainPractice Guidelines as Topiclipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase InhibitorsMetabolic syndromeCardiology and Cardiovascular MedicineLipid profilebusinessDyslipidemiaAmerican Journal of Cardiovascular Drugs
researchProduct

Aldosterone biosynthesis induced by ACTH and angiotensin II in newborn rat adrenocortical cells transfected by c-EJ-Ha-ras oncogene

1991

Abstract Adrenocortical cells were obtained by fractionated trypsination of newborn rat adrenal glands and transfected with a plasmid containing the EJ T24 -Ha-ras oncogene. Isolation of adhesive cells led to a proliferative cell line with an overexpression of 21 kDa ras protein. These cells incubated with corticosterone or deoxycorticosterone as the precursor produced a high level of 18-hydroxycorticosterone and aldosterone as identified by gas chromatography- mass spectrometry. ACTH and angiotensin II increased the basal production of aldosterone nineteen-fold and six-fold respectively. Under ACTH stimulation the ratio between aldosterone and 18-hydroxycorticosterone production was 1:3. T…

medicine.medical_specialtyBiophysicsBiologyPeptide hormoneTransfectionBiochemistryMass SpectrometryProto-Oncogene Proteins p21(ras)chemistry.chemical_compoundAdrenocorticotropic HormoneCorticosteroneInternal medicineAdrenal GlandsmedicineAnimals18-HydroxycorticosteroneAldosteroneMolecular BiologyChromatography High Pressure LiquidAldosteroneOncogeneAdrenal cortexCell growthAngiotensin IICell BiologyAngiotensin IIRatsEndocrinologymedicine.anatomical_structurechemistryCell cultureBiochemical and Biophysical Research Communications
researchProduct

Autoimmune pancreatitis: A challenging diagnostic puzzle for clinicians

2010

Autoimmune pancreatitis is a form of pancreatitis with autoimmune stigmata that may present as either focal or diffuse gland involvement. In focal forms, autoimmune pancreatitis shares demographic, clinical, biochemical and imaging features with pancreatic cancer. Since autoimmune pancreatitis is a benign disease and steroid therapy can rapidly resolve symptoms, improve radiological findings and avoid unnecessary surgery, the current clinical challenge is how to differentiate autoimmune pancreatitis from pancreatic neoplasia. Even though definitive diagnosis of the disease is difficult, several diagnostic criteria have been proposed and progress has been made in imaging studies. The managem…

medicine.medical_specialtyBiopsyAutoimmune Diseases; Biopsy; Cholangiopancreatography; Endoscopic Retrograde; Contrast Media; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatitis; Positron-Emission Tomography; Tomography; X-Ray ComputedUnnecessary SurgeryContrast MediaDiseaseGastroenterologyAutoimmune DiseasesEndoscopic RetrogradeFluorodeoxyglucose F18Internal medicinePancreatic cancerBiopsymedicineHumansIntensive care medicineTomographyAutoimmune pancreatitisCholangiopancreatography Endoscopic RetrogradeHepatologymedicine.diagnostic_testBenign diseasebusiness.industryGastroenterologymedicine.diseaseMagnetic Resonance ImagingCholangiopancreatographyX-Ray ComputedSteroid therapyPancreatitisPositron-Emission TomographyPancreatitisTomography X-Ray ComputedbusinessDigestive and Liver Disease
researchProduct

The influence of oxygen concentration during embryo culture on obstetric and neonatal outcomes: a secondary analysis of a randomized controlled trial.

2020

Abstract STUDY QUESTION Does oxygen concentration during 3-day embryo culture affect obstetric and neonatal outcomes? SUMMARY ANSWER Oxygen concentration during 3-day embryo culture does not seem to affect the obstetric and neonatal outcomes measured. WHAT IS KNOWN ALREADY Atmospheric oxygen appears to be harmful during extended embryo culture. Embryo culture conditions might therefore be a potential risk factor for subsequent fetal development and the health of future children. No data are available concerning the obstetrics and neonatal outcomes after Day 3 transfer of embryos cultured under reduced and atmospheric oxygen tensions. STUDY DESIGN, SIZE, DURATION A secondary analysis of a pr…

medicine.medical_specialtyBirth weight03 medical and health sciencesEgg donation0302 clinical medicinePregnancymedicineHumansChild030304 developmental biologyRetrospective Studies0303 health sciencesPregnancyFetus030219 obstetrics & reproductive medicineObstetricsbusiness.industryRehabilitationInfant NewbornPregnancy OutcomeObstetrics and GynecologyEmbryo culturemedicine.diseaseEmbryo TransferEmbryo transferOxygenReproductive MedicineSpainGestationFemaleLive birthbusinessObstetríciaLive Birth
researchProduct

Steroid activities comparison of natural and food wrap compounds in human breast cancer cell lines

2004

Abstract In this study, we tested and compared the endocrine disruption activities of compounds in materials used to package foods (bisphenol A, bisphenol F, and bisphenol A diglycidylether BADGE) with natural molecules (genistein, apigenin, kaempferol, and tangeretin) in the human breast cancer cell lines MCF-7 (ER + ) and MDA-MB453 (AR + ; GR + ). Octylphenol was also chosen as a xenoestrogen reference. Two compounds had no estrogenic activity: BADGE and tangeretin. Genistein was the most active compound in the E-Screen assay with MCF-7, followed by octylphenol, bisphenol F, bisphenol A and apigenin, with kaempferol the least potent. All estrogenic compounds competed with 17β-estradiol fo…

medicine.medical_specialtyBisphenol A[SDV]Life Sciences [q-bio]medicine.medical_treatmentGenisteinAntineoplastic AgentsBreast NeoplasmsEndocrine SystemToxicologySteroid03 medical and health scienceschemistry.chemical_compoundTangeretin0302 clinical medicinePhenolsInternal medicineTumor Cells CulturedmedicineAnticarcinogenic AgentsHumansEstrogens Non-SteroidalApigeninBenzhydryl CompoundsKaempferolsComputingMilieux_MISCELLANEOUS030304 developmental biologyFlavonoids0303 health sciencesDose-Response Relationship DrugFood PackagingGeneral MedicineFlavonesGenistein3. Good health[SDV] Life Sciences [q-bio]XenoestrogenEndocrinologyReceptors EstrogenchemistryMCF-7Receptors Androgen030220 oncology & carcinogenesisApigeninCarcinogensEpoxy CompoundsFemaleKaempferolhormones hormone substitutes and hormone antagonistsFood Science
researchProduct

Dose-dependent osteoinductive effects of bFGF in rabbits.

2009

Growth factors lead to the induction of tissue regeneration in bone healing when coated on biomaterials. Basic fibroblast growth factor (bFGF) combines osteoinduction and neoangiogenesis. This study evaluated bFGF-coated hydroxylapatite implants in two experimental groups with 10 or 100 microg (n = 5 per group) compared with uncoated control implants in the rabbit patellar groove model. We observed an unexpected ineffectiveness compared to the control groups with no significant difference of bone growth after 35 days. However, all samples from the 100 microg experiment (control and coated implant) showed significantly stronger 19-25 day label than both 10 microg groups (control and coated i…

medicine.medical_specialtyBone RegenerationClinical BiochemistryBasic fibroblast growth factorDose dependenceBone healingchemistry.chemical_compoundEndocrinologyCoated Materials BiocompatibleImplants ExperimentalOsteoclastInternal medicinemedicineAnimalsHumansBone growthDose-Response Relationship DrugHistologyCell BiologyPatellaHydroxylapatiteSurgerymedicine.anatomical_structureEndocrinologyDurapatiteTreatment OutcomechemistryModels AnimalFibroblast Growth Factor 2ImplantRabbitsGrowth factors (Chur, Switzerland)
researchProduct

Relation of PvuII site polymorphism in the COL1A2 gene to the risk of fractures in prepubertal Finnish girls.

2003

Genetic susceptibility to fractures may be detectable in early childhood. We evaluated the associations between the polymorphic PvuII site of the COL1A2 gene and bone properties assessed by different modalities (dual-energy X-ray absorptiometry; peripheral quantitative computed tomography; gel coupling scanning quantitative ultrasonometry; ultrasound bone sonometry), bone turnover markers, and the occurrence of fractures in 244 prepubertal Finnish girls. Tanner stage and physical characteristics did not differ significantly among girls with different COL1A2 genotypes. The polymorphism was not significantly associated with different bone properties or any of the bone turnover markers when gi…

medicine.medical_specialtyBone densityPhysiologyOsteoporosisBiologyPolymorphism Single NucleotideCollagen Type IBone remodelingFractures BoneBone DensityRisk FactorsInternal medicineGenotypeGeneticsmedicineHumansGenetic Predisposition to DiseaseTibiaQuantitative computed tomographyChildDeoxyribonucleases Type II Site-SpecificFinlandRetrospective StudiesBone mineralBinding SitesPolymorphism Geneticmedicine.diagnostic_testPubertyAnthropometrymedicine.diseaseEndocrinologyFemaleBone RemodelingCollagenPhysiological genomics
researchProduct

Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years.

1997

Two hundred and fifty-five postmenopausal women with distal forearm bone mineral density (BMD) 1 SD below the mean value for normal age-matched postmenopausal subjects were randomly allocated to a 2-year treatment with oral ipriflavone (200 mg t.i.d.) or a matched placebo, according to a double-masked, parallel-group design. All patients also received a 1 g/day calcium supplement. Distal radius BMD and bone metabolism markers were measured at baseline, and every 6 months. Blood haematology and chemistry and physical parameters were monitored at the same time. One hundred and ninety-six patients completed 2 years of treatment. BMD changes from baseline were analysed according to valid comple…

medicine.medical_specialtyBone diseaseEndocrinology Diabetes and MetabolismOsteoporosisUrologyPlaceboBone and BonesBone remodelingchemistry.chemical_compoundBone DensityHumansMedicineOsteoporosis PostmenopausalAgedBone mineralCreatinineIntention-to-treat analysisbusiness.industryMiddle Agedmedicine.diseaseIsoflavonesSurgeryHydroxyprolineRadiuschemistryFemaleIpriflavonebusinessmedicine.drug
researchProduct